CAS 149598-71-0: Spiro[2H-furo[2,3-e]isoindole-2,1'(2'H)-naphthalen]-6(3H)-one,3',4',4'a,5',6',7,7',8,8',8'a-decahydro-4,6'-dihydroxy-7-(2-hydroxyethyl)-2',5',5',8'a-tetramethyl-,(1'R,2'R,4'aS,6'R,8'aS)-

Stachybotramide preferentially stimulate the plasma cholesteryl ester transfer protein (CETP)-mediated transfer of cholesteryl esters (CE) from high density

(4aS,8R,8aS)-3,4'-Dihydroxy-7'-(2-hydroxyethyl)-4,4,7,8a-tetramethylspiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2'-3,8-dihydrofuro[2,3-E]isoindole]-6'-one is a complex natural product typically found in certain medicinal plants. It is a member of a class of spirocyclic compounds, known for their unique three-dimensional structures and potential bioactivity. This compound is primarily sourced from specific phytochemicals through extraction and isolation processes that preserve its structural integrity. Its mode of action involves interacting with various biological pathways, potentially affecting enzyme activity, receptor binding, or cellular signaling. Such interactions may impart a range of biological effects, including antioxidant, anti-inflammatory, or anticancer properties, although the specific mechanisms require further elucidation. In terms of applications, this compound is of significant interest in pharmacological research due to its potential utility in drug development. Researchers are investigating its effects in disease models to identify therapeutic advantages that may lead to novel treatments. The complexity of its structure also provides valuable insights into the design and synthesis of new molecular frameworks in medicinal chemistry.